- Shopping Bag ( 0 items )
"For the last two decades, pharmaceutical drug trials increasingly have been outsourced to nonacademic physicians, many of whom now devote a majority of their practice to conducting clinical trials. Fisher examines this trend and outlines many of the problems and risks entailed for both bioethics and economic policy. A valuable contribution to any course in the economics of health care or to more advanced courses in bioethics. Recommended."